Oral Ketamine Gets Orphan Drug Status for Rett Syndrome
The Company has completed a phase 2 trial which evaluated the efficacy and safety of oral ketamine in patients with Rett syndrome.
The Company has completed a phase 2 trial which evaluated the efficacy and safety of oral ketamine in patients with Rett syndrome.
But polypill with or without aspirin is associated with reduced functional decline for those aged 65 years or older with cardiovascular risk factors
Findings for assessments conducted both at 4 to 6 years and 7 to 9 years versus spontaneously conceived children
The CD20-directed cytolytic antibody therapy was approved based on data from two phase 3 trials.
Donanemab is an antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.
Recurrent benign paroxysmal positional vertigo resolved for 72.4 percent of patients using web-based system
AOC 1020 is designed to reduce the expression of DUX4 mRNA and DUX4 protein in muscles.
FDA grant accelerated approval to Alzheimer disease treatment; New fixed-dose asthma treatment; NERD therapy looks promising; Leukemia drug to be withdrawn in 2023; Pertussis prevention treatment approved for use during pregnancy.
Vamorolone is a first-in-class dissociative steroidal drug that retains the anti-inflammatory activity of corticosteroids but with a novel mechanism of action.